heino von prondzynski  epigenomics ag  zoominfocom heino von prondzynskis involvement in venture capital via quotient ltd want to see morewant to find out who got funded and who’s funding the next big thing in real time all across the world tailored to your specific areas of focus deals per dayget access to the most exhaustive worldwide funding watch on the webcomprehensive funding informationknow about who invested in a company which sites covered the event the funding history etcexclusive insightsview original analytics such as most dynamic industries most active investors and morestay awareget emailed when deals critical to your business happen filter by region industry and topics of interestas seen onhave a loginsign inregister nowits freeuse your social accountor fill in the quick formregister nowpromise we wont spamsign invia your social accountvia your existing wgf accountremember meregister its freeforgot your passwordsign inforgot your passwordenter your email and we will send you your new passwordreset passwordthe worlds largest funding basepeopleheinovonprondzynskisectionpeoplesubsectiondetailid search deals by company name industry location investors search heinovon prondzynskiget alertedif heino von prondzynski gets fundedheino von prondzynskiquotient ltd  directordeals involving heino von prondzynski raised with quotient ltd on december please note that all data is automatically extracted and errors can occurthe whogotfunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and completesome of the profile information was collected using the crunchbase api for more details on the profile please check heino von prondzynsk on crunchbaseinaccurate data help us improve whogotfunded post a comment   heino von prondzynski executive profile  biography  bloomberg july    am et biotechnology company overview of epigenomics ag snapshotpeople  overviewboard memberscommittees executive profile heino von prondzynski chairman of the supervisory board  epigenomics agagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships€ background mr heino von prondzynski served as the head of diagnostics division at roche holding ag from  to december   mr von prondzynski served as the chief executive officer of roche diagnostics gmbh from december   to january   he served as the chief executive officer of roche diagnostics corporation mr von prondzynski is an independent consultant he served as a sales representative and marketing manager of troponwerke since  general manager  of pharmaceuticals and diagnostics business in austria of bayer ltd since  general manager of health care sector of bayer since  general manager of bayer diagnostics since  general manager and chief executive officer of chiron behring gmbh since  general manager and chief executive officer of italy since  and president and head of vaccines division at chiron vaccines since  from  to  he held several executive positions including president of vaccine business at chiron corporation from  to  he held sales and marketing and general management positions at bayer ag he served as chief executive officer of bayer do brasil healthcare sector mr von prondzynski has been chairman of supervisory board at epigenomics ag since may   he serves as chairman of supervisory board at henkel corp he serves as president of the supervisory board at htlstrefa sa he served as the chairman of vt finance ag since april  he served as the chairman of nobel biocare holding ag from may  to july   he served as a vice chairman of vt finance ag from  to april  mr von prondzynski has been a lead independent director and director of quotient limited since september  he has been a director of hospira inc since march  he has been a member of supervisory board at philips new zealand limited and philips malaysia sdn bhd since  mr von prondzynski serves as a member of supervisory board at htlstrefa sa he has been a member of supervisory board at philips medical systems international bv philips electronics australia limited and koninklijke philips nv since  he serves as a director of supervisory board of royal philips amsterdam the netherlands he served as a member of the management board of henkel kgaa from march   to april   he served as a member of executive committee at f hoffmanla roche ltd from early  to  he served as a nonexecutive director of imed holdings pty limited since june   mr von prondzynski served as a member of supervisory board at qiagen nv from  to june   he served as a director of caridian bct denver usa he served as independent director of tecan holding ag switzerland he served as a director of nobel biocare holding ag from march  to july   mr von prondzynski served as a director of vt finance ag he served as a director of tecan group ltd until february   he served as a member of supervisory board at epigenomics ag from may   to march   he is an honorary member of real and benemerita sociedade beneficiencia do rio de janeiro and chairman of the association of friends of einsiedeln abbey mr von prondzynski studied mathematics geography and history at westfälische wilhelms university of münster in germanyread full background corporate headquarters geneststrasse berlin berlin germanyphone    fax     board members memberships presentindependent directorhospira incpresentlead independent directorquotient limited education unknownother education westfälische wilhelmsuniversität münster other affiliations qiagen nvkoninklijke philips nvroche holding agphilips medical systems international bvnobel biocare holding agvt finance agroche diagnostics gmbhroche diagnostics corporationphilips malaysia sdn bhdphilips new zealand limitedwestfälische wilhelmsuniversität münstertecan group ltdhospira incphilips electronics australia limitedimed holdings pty limitedhtlstrefa saquotient limited annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation total annual cash compensation€total calculated compensation€ request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact epigenomics ag please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close qtnt heino von prondzynski insider trades for quotient ltd bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close quotient ltd nasdaq qtnt go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus quotient ltd after hours  quotes are delayed by  min jul    pm qtnt quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual heino von prondzynski mr heino von prondzynski is lead independent director at quotient ltd chairmansupervisory board at epigenomics ag membersupervisory board at royal philips nv and chairmansupervisory board at htlstrefa sa he is on the board of directors at quotient ltd and royal philips nv mr von prondzynski was previously employed as chairman by nobel biocare holding ag independent director by hospira inc independent directorsupervisory board by qiagen nv chief executive officerdiagnostics division by f hoffmannla roche ltd chief executive officer by roche diagnostics corp presidentvaccines division by chiron corp general manager by bayer ag and general manager by bayer sa brazil he also served on the board at bb medtech ag and caridianbct inc he received his undergraduate degree from the university of münster transactions date shares transaction value     derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr paul cowan chairman ceo  headinvestor relations mr edward farrell copresident mr jeremy stackawitz copresident mr christopher j lindop chief financial officer mr john allan chief technology officer  senior vice president mr roland w boyd treasurer  controller dr john wilkerson independent director mr frederick stanislaus hallsworth independent director mr zubeen shroff independent director mr brian mcdonough independent director mr thomas a bologna independent director ms sarah a oconnor independent director mr heino von prondzynski lead independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest a insanely cool college classes that will have you longing to hit the books abernie sanders and larry david are related — and so are these other surprising celebs abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft quotient appoints heino von prondzynski to board of directors  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street quotient appoints heino von prondzynski to board of directors globenewswire sep    am edt jersey channel islands sept   globe newswire  quotient limited nasdaqqtnt a commercialstage diagnostics company today announced the appointment of heino von prondzynski to the companys board of directors mr von prondzynski will also serve as the companys lead independent director mr von prondzynski brings strong executive management and diverse global experience from leadership positions held at several major multinational healthcare companies i am delighted to announce the appointment of heino as a director of quotient commented paul cowan chairman and chief executive officer of quotient he has had a highly distinguished career in the healthcare industry delivering global growth and profitable expansion with over  years experience in the field of pharmaceuticals vaccines and medical diagnostics heino has shown a keen interest in talent development and a passion for driving product innovation mr von prondzynski  served as chief executive officer of roche diagnostics and as a member of the executive committee of f hoffmanla roche ltd from early  to  retiring from roche at the end of  while at roche he brought roche diagnostics which included diabetes nearpatient testing centralized diagnostics and applied science to global market leadership and record profitability he also drove significant growth through an expansion of roches molecular diagnostics portfolio and entry into the donorscreening market from  to  mr von prondzynski held several executive positions including president of the vaccine business at chiron corporation a multinational firm developing biopharmaceuticals vaccines and bloodtesting products earlier in his career mr von prondzynski held sales and marketing and general management positions at bayer ag mr von prondzynski currently serves on a number of public company boards of directors including royal philips netherlands hospira inc usa and epigenomics ag germany about quotient limited quotient limited quotient is an established commercialstage diagnostics company committed to reducing healthcare costs and improving patient care through the development and commercialization of innovative tests currently focused on blood grouping and serological disease screening quotient is developing its proprietary mosaiq tm technology platform to offer a breadth of tests that is unmatched by any commercially available transfusion diagnostic instrument platform the companys operations are based in edinburgh scotland newtown pennsylvania and eysins switzerland contact paul cowan chairman  chief executive officer paulcowanquotientbdcom     trending ftc seen as set to block rite aid deal it would be crazy to clean house at wells fargo ceo says tesaro resorts to pr razzle dazzle to make ovarian cancer drug appear cheaply priced advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers quotient appoints heino von prondzynski to board of directors nasdaqqtnt english français register sign in quotient appoints heino von prondzynski to board of directors september    et  source quotient limited jersey channel islands sept   globe newswire  quotient limited nasdaqqtnt a commercialstage diagnostics company today announced the appointment of heino von prondzynski to the companys board of directors mr von prondzynski will also serve as the companys lead independent director mr von prondzynski brings strong executive management and diverse global experience from leadership positions held at several major multinational healthcare companies i am delighted to announce the appointment of heino as a director of quotient commented paul cowan chairman and chief executive officer of quotient he has had a highly distinguished career in the healthcare industry delivering global growth and profitable expansion with over  years experience in the field of pharmaceuticals vaccines and medical diagnostics heino has shown a keen interest in talent development and a passion for driving product innovation mr von prondzynski  served as chief executive officer of roche diagnostics and as a member of the executive committee of f hoffmanla roche ltd from early  to  retiring from roche at the end of  while at roche he brought roche diagnostics which included diabetes nearpatient testing centralized diagnostics and applied science to global market leadership and record profitability he also drove significant growth through an expansion of roches molecular diagnostics portfolio and entry into the donorscreening market from  to  mr von prondzynski held several executive positions including president of the vaccine business at chiron corporation a multinational firm developing biopharmaceuticals vaccines and bloodtesting products earlier in his career mr von prondzynski held sales and marketing and general management positions at bayer ag mr von prondzynski currently serves on a number of public company boards of directors including royal philips netherlands hospira inc usa and epigenomics ag germany about quotient limited quotient limited quotient is an established commercialstage diagnostics company committed to reducing healthcare costs and improving patient care through the development and commercialization of innovative tests currently focused on blood grouping and serological disease screening quotient is developing its proprietary mosaiqtm technology platform to offer a breadth of tests that is unmatched by any commercially available transfusion diagnostic instrument platform the companys operations are based in edinburgh scotland newtown pennsylvania and eysins switzerland paul cowan chairman  chief executive officer paulcowanquotientbdcom     related articles other press releases by quotient limited quotient limited to report continued progress on the commercial scaleup of mosaiq™ and fiscal first quarter  financial results and host conference call july    quotient limited to participate in the jefferies  global healthcare conference may    quotient limited reports continued progress on the commercial scaleup of mosaiq and fourth quarter and fiscal year  financial results may    quotient limited to participate in the ubs global healthcare conference may    quotient limited to report fourth quarter and fiscal year  financial results and host conference call may     other news releases in directors and officers in the last  days profile quotient limited   subscribe via rss  subscribe via atom  javascript newtown pennsylvania united states contact data paul cowan chairman  chief executive officer paulcowanquotientbdcom     contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files quotient limited logo logo url  copy the link below formats available original medium small tags medical management changes newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved